Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Enhancement of 5-fluorouracil incorporation into human lymphoblast ribonucleic acid.

Literature DB >> 6972217

Enhancement of 5-fluorouracil incorporation into human lymphoblast ribonucleic acid.

D W Kufe, E M Egan.

Abstract

Entities: Chemical Species

Mesh：

Substances：

Year: 1981 PMID： 6972217 DOI： 10.1016/0006-2952(81)90183-0

Source DB: PubMed Journal: Biochem Pharmacol ISSN： 0006-2952 Impact factor: 5.858

Keyword Cloud
Cited

× No keyword cloud information.

16 in total

1. Phase I trial of fluorouracil modulation by N-phosphonacetyl-L-aspartate and 6-methylmercaptopurine ribonucleoside (MMPR), and leucovorin in patients with advanced cancer.

Authors: A Hageboutros; G R Hudes; F Greene; F P LaCreta; J Brennan; P J O'Dwyer
Journal: Invest New Drugs Date: 1997 Impact factor: 3.850

2. The effect of structural modifications of 5-fluorouracil derivatives on their transport and biodegradation by isolated rat jejunum.

Authors: L Novotný; H Farghali; I Janků; J Beránek
Journal: Cancer Chemother Pharmacol Date: 1989 Impact factor: 3.333

3. Phase I trial of the combination of 6-methylmercaptopurine riboside and 5-fluorouracil.

Authors: M C Wiemann; G W Crabtree; A B Weitberg; E N Spremulli; F J Cummings; C Murray; P Calabresi
Journal: Med Oncol Tumor Pharmacother Date: 1988

4. Biochemical mechanisms for the scheduled synergism of (alpha S, 5S)-2 amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid and 5-fluorouracil in P388 leukemia.

Authors: B Ardalan; B Chandrasekaran; H J Hrishikeshavan
Journal: Cancer Chemother Pharmacol Date: 1985 Impact factor: 3.333

10. 5-Fluorouracil incorporated into the tissue RNA of human and rat bladder carcinoma after administration of 1-(2-tetrahydrofuryl)-5-fluorouracil combined with uracil.

Authors: Shigehiro Tsujimoto; Kiyohide Fujimoto; Eijiro Okajima; Seiichiro Ozono; Eigoro Okajima; Yoshihiko Hirao
Journal: Int J Clin Oncol Date: 2008-05-08 Impact factor: 3.402

Enhancement of 5-fluorouracil incorporation into human lymphoblast ribonucleic acid.

1. Phase I trial of fluorouracil modulation by N-phosphonacetyl-L-aspartate and 6-methylmercaptopurine ribonucleoside (MMPR), and leucovorin in patients with advanced cancer.

2. The effect of structural modifications of 5-fluorouracil derivatives on their transport and biodegradation by isolated rat jejunum.

3. Phase I trial of the combination of 6-methylmercaptopurine riboside and 5-fluorouracil.

4. Biochemical mechanisms for the scheduled synergism of (alpha S, 5S)-2 amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid and 5-fluorouracil in P388 leukemia.

5. Phase I clinical trial of 5-fluoro-pyrimidinone (5FP), an oral prodrug of 5-fluorouracil (5FU).

6. Sequential methotrexate (MTX) and 5-fluorouracil (FU) in human tumor xenografts.

7. Effects of ciprofloxacin on eucaryotic pyrimidine nucleotide biosynthesis and cell growth.

8. Modulation of 5-FU metabolism in human MCF-7 breast carcinoma cells.

9. Phase I trial of fluorouracil modulation by N-phosphonacetyl-L-aspartate and 6-methylmercaptopurine ribonucleoside.

10. 5-Fluorouracil incorporated into the tissue RNA of human and rat bladder carcinoma after administration of 1-(2-tetrahydrofuryl)-5-fluorouracil combined with uracil.